Topcon 3D OCT-1 Maestro Reference Database Study II

Completed

• Conditions: Healthy
• Interventions: Device: 3D OCT-1 Maestro

• Registration Number: NCT02447120
• Lead Sponsor: Topcon Medical Systems, Inc.

Brief Summary

The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.

Detailed Description

The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.

Study Timeline

• Study Start: 2015-05
• Study First Submitted: 2015-05-12
• Study First Submitted QC: 2015-05-13
• Study First Posted: 2015-05-18
• Primary Completion: 2015-10
• Study Completion: 2015-10
• Status Verified: 2022-06
• Last Update Submitted: 2022-06-06
• Last Update Posted: 2022-06-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 504

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Normal Eyes	3D OCT-1 Maestro	Subjects with no known ocular diseases will be scanned with the Maestro device

Primary Outcome Measures

Name	Time	Method
Retinal Thickness	1 minute

Trial Locations

Locations (7)

UAB School of Optometry; 🇺🇸 Birmingham, Alabama, United States

Valley Eyecare Center; 🇺🇸 Livermore, California, United States

Southern California College of Optometry; 🇺🇸 Fullerton, California, United States

Western University of Health Sciences; 🇺🇸 Pomona, California, United States

Illinois College of Optometry; 🇺🇸 Chicago, Illinois, United States

SUNY College of Optometry; 🇺🇸 New York, New York, United States

New York VA; 🇺🇸 Jamaica, New York, United States